Dice CEO: Energy, T...
Health Care: Drugs
BioMarin Pharmaceuticals Inc (BMRN: NASDAQ)
$35.53 -0.11 | -0.31%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.16 | 0.58 | 0.98 |
| Price to Sales (TTM) | 9.16 | 4.62 | 1.42 |
| Price to Book (MRQ) | 5.33 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 7.48 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -130.00 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -29.60 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 6.60 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 17.30 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 34.34 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 47.67 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 2.80 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 4.30 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.42 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.45 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 91.40 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 87.00 | 83.50 | 47.70 |
| EBITD Margin (TTM) | -2.80 | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -12.71 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -15.20 | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -3.00 | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.16 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 10.70 | 5.30 | 7.00 |
| Return on Assets (TTM) | -5.70 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | 3.20 | 2.20 | 2.50 |
| Return on Investment (TTM) | -6.70 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | 3.70 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 447,656.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -73,290.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.20 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | 0.30 | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.40 | 0.40 | 0.40 |
Portfolios with BMRN
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- UserScottrade IRA
- UserEverett Bishop Portfolio 1
- ContributorEarnings Short Squeeze Play...
- Userwjwallace Portfolio
- ContributorStocks At New 52-Week Highs...
- ProColumbia Wanger Asset Manag...
- Contributor21 Stocks to Watch
- ContributorBreakout Stocks Of The Week...
Latest BMRN Headlines from TheStreet
- BioMarin Stock Falls On Unusually High Volume (BMRN) 05.31.12 | 02:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.29.12 | 10:05 am
- 8 Stocks Rising on Big Volume 05.21.12 | 01:05 pm
- 5 Stocks Hit 52-Week Highs 05.16.12 | 01:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.16.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.27.12 | 03:04 am
- BioMarin Pharmaceutical's CEO Discusses Q4 2011 Earning Results - Earnings Call Transcript 02.16.12 | 11:02 pm
- 5 Earnings Stocks Poised to Pop 02.16.12 | 12:02 pm
- BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
Press Releases for BMRN
- IU Confidential Publishes Biotech Investment Report - PR Newswire 07.28.11 | 09:07 am
- BioMarin Launches Firdapse In The European Union - PR Newswire 04.19.10 | 09:04 am
- BioMarin To Present At The Barclays Capital Global Healthcare Conference - PR Newswire 03.17.10 | 09:03 am
- BioMarin To Acquire LEAD Therapeutics - PR Newswire 02.04.10 | 04:02 pm
Partner Headlines for BMRN
- BioMarin Prices Share Offering - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Analyst Insights: Finish Line, BioMarin Pharma, Laboratory Corp, Ocz Technology, AstraZeneca May 31st - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Loss at BioMarin Wider Than Expected - Analyst Blog - Zacks 02.17.12 | 09:02 am
- Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone and United Parcel Services - Press Releases - Zacks 02.14.12 | 09:02 am
- BioMarin Pharmaceutical (BMRN) - Bear of the Day - Zacks 02.14.12 | 01:02 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 02.08.12 | 09:02 am
- BioMarin's Facility Expansion Backed - Analyst Blog - Zacks 12.22.11 | 10:12 am
- Facility Expansion at BioMarin - Analyst Blog - Zacks 11.29.11 | 10:11 am
- Activist Hedge Fund Accipiter Capital's Top Stock Picks - Seeking Alpha 11.29.11 | 09:11 am
